Toxoplasmic Encephalitis in AIDS
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Involvement of the central nervous system (CNS) is common in patients with advanced disease due to human immunodeficiency virus (HIV). Symptoms range from lethargy and apathy to coma, incoordination and ataxia to hemiparesis, loss of memory to severe dementia, and focal to major motor seizures. Involvement may be closely associated with HIV infection per se, as in the AIDS dementia complex, but is frequently caused by opportunistic pathogens such as Toxoplasma gondii and Cryptococcus neoformans or malignancies such as primary lymphoma of the CNS. The clinical presentations of attendant and direct CNS involvement are remarkably non-specific and overlapping, yet a correct diagnosis is critical to successful intervention. Toxoplasmic encephalitis is one of the most common and most treatable causes of AIDS-associated pathology of the CNS. A great deal has been learned in the last 10 years about its unique presentation in the HIV-infected patient with advanced disease. Drs. Benjamin J. Luft of the State University of New York at Stony Brook and Jack S. Remington of the Stanford University School of Medicine and Palo Alto Medical Foundation's Research Institute have studied T. gondii for many years and are two of the leading experts in the field. This commentary comprises an update of their initial review (J Infect Dis 1988;157:1-6) and a presentation of the current approaches to diagnosing and managing toxoplasmic encephalitis in HIV-infected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levy, R. M., Bredesen, D. E., & Rosenblum, M. L. (1985) · Journal of Neurosurgery · doi:10.3171/jns.1985.62.4.0475 · Cited by 1,129
Burg, J. L., Grover, C. M., Pouletty, P., & Boothroyd, J. C. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.8.1787-1792.1989 · Cited by 897
Toxoplasmic Encephalitis in Patients With Acquired Immune Deficiency Syndrome
Luft, B. J. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350070031018 · Cited by 714
Self-citationGazzinelli, R. T., Hakim, F. T., Hieny, S., Shearer, G. M., & Sher, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.1.286 · Cited by 621
NAVIA, B. A., Petito, C. K., GOLD, J. W. M., Cho, E., Jordan, B. D., & Price, R. W. (1986) · Annals of Neurology · doi:10.1002/ana.410190303 · Cited by 504
Dannemann, B., McCutchan, J. A., Israelski, D., Antoniskis, D., Leport, C., Luft, B., Nussbaum, J., Clumeck, N., Morlat, P., Chiu, J., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-33 · Cited by 360
Self-citationImportance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice.
Suzuki, Y., Conley, F. K., & Remington, J. S. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.2045 · Cited by 353
Self-citationAcquired Immunodeficiency Syndrome in African Patients
Clumeck, N., Sonnet, J., Taelman, H., Mascart-Lemone, F., De Bruyere, M., Vandeperre, P., Dasnoy, J., Marcelis, L., Lamy, M., Jonas, C., et al. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402233100804 · Cited by 301 · cited 3×
“In Africa, Haiti, Europe, and Latin America, where the incidence of latent infection is much higher, the number of individuals with AIDS who develop TE will be three to four times greater than that in the United States [3-5].”
BackgroundMurray, H. W., & Teitelbaum, R. F. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/165.3.513 · Cited by 177
Engstrom, J. W., Lowenstein, D. H., & Bredesen, D. E. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90379-3 · Cited by 163
Cited by
Toxoplasma gondii: from animals to humans
Tenter, A. M., Heckeroth, A. R., & Weiss, L. M. (2000) · International Journal for Parasitology · doi:10.1016/s0020-7519(00)00124-7 · Cited by 3,702
Montoya, J., & Liesenfeld, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16412-x · Cited by 3,232
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Robert-Gangneux, F., & Dardé, M.-L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05013-11 · Cited by 1,815
Howe, D. K., & Sibley, L. D. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.6.1561 · Cited by 1,445
Toxoplasma gondii: transmission, diagnosis and prevention
Hill, D., & Dubey, J. P. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00485.x · Cited by 1,173
Toxoplasmosis: A history of clinical observations
Weiss, L. M., & Dubey, J. P. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2009.02.004 · Cited by 885
Toxoplasma Invasion of Mammalian Cells Is Powered by the Actin Cytoskeleton of the Parasite
Dobrowolski, J. M., & Sibley, L. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81071-5 · Cited by 645
DUBEY, J. P., LAGO, E. G., GENNARI, S. M., SU, C., & JONES, J. L. (2012) · Parasitology · doi:10.1017/s0031182012000765 · Cited by 614
Chapter 3: Molecular Tools for Genetic Dissection of the Protozoan Parasite Toxoplasma gondii
(1995) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61845-2 · Cited by 595
Lytic Cycle of Toxoplasma gondii
Black, M. W., & Boothroyd, J. C. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.3.607-623.2000 · Cited by 554
Biology and epidemiology of Toxoplasma gondii in man and animals
Hill, D. E., Chirukandoth, S., & Dubey, J. P. (2005) · Animal Health Research Reviews · doi:10.1079/ahr2005100 · Cited by 519
Highly Endemic, Waterborne Toxoplasmosis in North Rio de Janeiro State, Brazil
Bahia-Oliveira, L. M. G., Jones, J. L., Azevedo-Silva, J., Alves, C. C. F., Oréfice, F., & Addiss, D. G. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0901.020160 · Cited by 518
ToxoDB: an integrated Toxoplasma gondii database resource
Gajria, B., Bahl, A., Brestelli, J., Dommer, J., Fischer, S., Gao, X., Heiges, M., Iodice, J., Kissinger, J. C., Mackey, A. J., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm981 · Cited by 478
Donald, R. G. K., Carter, D., Ullman, B., & Roos, D. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14010 · Cited by 414
Kiss and spit: the dual roles of Toxoplasma rhoptries
Boothroyd, J. C., & Dubremetz, J.-F. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1800 · Cited by 406
Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome
Luft, B. J., Hafner, R., Korzun, A. H., Leport, C., Antoniskis, D., Bosler, E. M., Bourland, D. D., Uttamchandani, R., Fuhrer, J., Jacobson, J., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291403 · Cited by 405
Self-citationDrug repurposing and human parasitic protozoan diseases
Andrews, K. T., Fisher, G., & Skinner-Adams, T. S. (2014) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2014.02.002 · Cited by 383
Prevention of toxoplasmosis in transplant patients
Derouin, F., & Pelloux, H. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02091.x · Cited by 365
Conrad, P. A., Miller, M. A., Kreuder, C., James, E. R., Mazet, J., Dabritz, H., Jessup, D. A., Gulland, F., & Grigg, M. E. (2005) · International Journal for Parasitology · doi:10.1016/j.ijpara.2005.07.002 · Cited by 341
Toxoplasma Effectors Targeting Host Signaling and Transcription
Hakimi, M.-A., Olias, P., & Sibley, L. D. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-17 · Cited by 339
(2013) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53490-3.00008-x · Cited by 335
Cameroonian Medicinal Plants: Pharmacology and Derived Natural Products
Kuete, V., & Efferth, T. (2010) · Frontiers in Pharmacology · doi:10.3389/fphar.2010.00123 · Cited by 321
Microarray Analysis Reveals Previously Unknown Changes in Toxoplasma gondii-infected Human Cells
Blader, I. J., Manger, I. D., & Boothroyd, J. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100951200 · Cited by 300
Suss-Toby, E., Zimmerberg, J., & Ward, G. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8413 · Cited by 297
Control of human toxoplasmosis
Smith, N. C., Goulart, C., Hayward, J. A., Kupz, A., Miller, C. M., & van Dooren, G. G. (2021) · International Journal for Parasitology · doi:10.1016/j.ijpara.2020.11.001 · Cited by 286
Lipid droplets in the nervous system
Ralhan, I., Chang, C.-L., Lippincott-Schwartz, J., & Ioannou, M. S. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202102136 · Cited by 281
“HIV infection and latency induce a unique metabolic signature in human macrophages.”
BackgroundInfluentialDe novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii
Fox, B. A., & Bzik, D. J. (2002) · Nature · doi:10.1038/415926a · Cited by 275
The development and biology of bradyzoites of toxoplasma gondii
Weiss, L. (2000) · Frontiers in Bioscience · doi:10.2741/weiss · Cited by 266
Surface antigens of Toxoplasma gondii: variations on a theme
Lekutis, C., Ferguson, D. J. P., Grigg, M. E., Camps, M., & Boothroyd, J. C. (2001) · International Journal for Parasitology · doi:10.1016/s0020-7519(01)00261-2 · Cited by 265
Cats and Toxoplasma: Implications for Public Health
Dabritz, H. A., & Conrad, P. A. (2010) · Zoonoses and Public Health · doi:10.1111/j.1863-2378.2009.01273.x · Cited by 262
Real-Time PCR for Quantitative Detection of Toxoplasma gondii
Lin, M.-H., Chen, T.-C., Kuo, T.-T., Tseng, C.-C., & Tseng, C.-P. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4121-4125.2000 · Cited by 260
Katlama, C., De Wit, S., O'Doherty, E., Van Glabeke, M., Clumeck, N., & European Network for Treatment of AIDS (ENTA) Toxoplasmosis Study Group (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.268 · Cited by 253
Toxoplasmosis: A global threat
Furtado, J., Smith, J., Belfort, R., Gattey, D., & Winthrop, K. (2011) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.83536 · Cited by 243
“[38] A wide range of nonspecific symptoms, such as dementia, ataxia, lethargy, seizures, can be present, which makes the clinical diagnosis difficult to make,[39] and TE should be suspected, especially in areas with a higher prevalence of the disease, like South America.”
BackgroundImmunology of Toxoplasma gondii
Munoz, M., Liesenfeld, O., & Heimesaat, M. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00992.x · Cited by 239
“The clinical presentation includes focal encephalitis with headache, confusion, motor weakness, and fever (7, 19, 30).”
BackgroundInfluentialAjzenberg, D., Yera, H., Marty, P., Paris, L., Dalle, F., Menotti, J., Aubert, D., Franck, J., Bessières, M., Quinio, D., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597477 · Cited by 216
“This confirms the predominance of toxoplasmic encephalitis in patients with AIDS [4], but also underscores the fact that pulmonary toxoplasmosis is relatively common.”
BackgroundNeurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondii
Cabral, C. M., Tuladhar, S., Dietrich, H. K., Nguyen, E., MacDonald, W. R., Trivedi, T., Devineni, A., & Koshy, A. A. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005447 · Cited by 209
“Prior to the introduction of effective combination anti-retroviral therapy, Toxoplasma was the most common cause of focal neurologic disease in AIDS patients [4].”
BackgroundHigh-Throughput Growth Assay for Toxoplasma gondii Using Yellow Fluorescent Protein
Gubbels, M.-J., Li, C., & Striepen, B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.309-316.2003 · Cited by 186
“gondii causes a life-threatening opportunistic infection, with Toxoplasma encephalitis as its most severe manifestation (23, 24).”
BackgroundHIV-Related Cerebral Toxoplasmosis Revisited: Current Concepts and Controversies of an Old Disease
Vidal, J. E. (2019) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325958219867315 · Cited by 183
“As the number of PLWHA increased, cerebral toxoplasmosis became one of the most frequent opportunistic infections and the most common causes of focal brain lesions in this population.(7) The most accepted explanation to the strong association between reactivated cerebral toxoplasmosis and AIDS is that these immunocomp…”
BackgroundMethodInfluentialToxoplasma gondii dissemination: a parasite's journey through the infected host
Harker, K. S., Ueno, N., & Lodoen, M. B. (2015) · Parasite Immunology · doi:10.1111/pim.12163 · Cited by 170
Focal Neurological Disease in Patients with Acquired Immunodeficiency Syndrome
Skiest, D. J. (2002) · Clinical Infectious Diseases · doi:10.1086/324350 · Cited by 164
“Up to 10% of patients may present with a diffuse encephalitis without any visible focal lesions [14].”
BackgroundFox, B. A., Guevara, R. B., Rommereim, L. M., Falla, A., Bellini, V., Pètre, G., Rak, C., Cantillana, V., Dubremetz, J.-F., Cesbron-Delauw, M.-F., et al. (2019) · mBio · doi:10.1128/mbio.00589-19 · Cited by 89
“If host immunity wanes, cyst reactivation causes toxoplasmic encephalitis (12, 13).”
BackgroundHiszczyńska-Sawicka, E., Olędzka, G., Holec-Gąsior, L., Li, H., Xu, J. B., Sedcole, R., Kur, J., Bickerstaffe, R., & Stankiewicz, M. (2011) · Veterinary Parasitology · doi:10.1016/j.vetpar.2010.11.047 · Cited by 73
Moen, K. E., & Moreno, S. N. J. (2026) · mBio · doi:10.1128/mbio.03124-25
Metadata
- Authors
- Luft, B. J., & Remington, J. S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-08-01
- Volume
- 15
- Issue
- 2
- Pages
- 211-222
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2065654101
- Cited by
- 1,287
- References
- 19
- FWCI
- 28.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.